Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
After 'complete standstill,' biotech market reaches new normal
The first half of 2025 was brutal for biotech, but investors are still keen on therapeutics in several areas, such as cardiorenal and neuropsych.
Gabrielle Masson
Aug 20, 2025 11:04am
CSL to lose up to 15% of staff, cut R&D costs, spin out vaccines
Aug 19, 2025 7:06am
ARPA-H data chief departs over mRNA vax cancellations
Aug 12, 2025 12:15pm
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
UK puts down $335M for new pandemic preparedness research center
Jul 17, 2025 1:09pm
BioNTech's chief strategy officer heads for the exit
Jul 17, 2025 10:55am
